Compare UNCY & OIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNCY | OIO |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 139.7M |
| IPO Year | 2021 | N/A |
| Metric | UNCY | OIO |
|---|---|---|
| Price | $6.72 | $3.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $44.50 | N/A |
| AVG Volume (30 Days) | ★ 431.9K | 21.6K |
| Earning Date | 04-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $2.90 |
| 52 Week High | $7.57 | $3.47 |
| Indicator | UNCY | OIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | N/A |
| Support Level | $6.48 | N/A |
| Resistance Level | $6.82 | N/A |
| Average True Range (ATR) | 0.31 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 23.49 | 0.00 |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.